Can Bydureon Bounce Back? Amylin's Proposed Cardio Safety Trial Is A Faster Option
If FDA approves the new protocol, a QT prolongation study required to refile Bydureon could commence this quarter.
If FDA approves the new protocol, a QT prolongation study required to refile Bydureon could commence this quarter.